Early Phase 1 Multiple System Atrophy Clinical Trials
4 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–4 of 4 trials
Recruiting
Early Phase 1
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
Multiple System AtrophyParkinson DiseaseAutonomic Failure+2 more
Vanderbilt University Medical Center31 enrolled1 locationNCT04620382
Recruiting
Early Phase 1
PET Imaging Evaluation of [11C]SY08
Multiple System AtrophyDementia With Lewy BodiesParkinson's Disease
Massachusetts General Hospital40 enrolled1 locationNCT06098612
Recruiting
Early Phase 1
[18F]ACI-15916 PET in α-synucleinopathies
Parkinson's Disease (PD)Multiple System Atrophy (MSA)Dementia With Lewy Bodies (DLB)
AC Immune SA46 enrolled1 locationNCT06891703
Recruiting
Early Phase 1
The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
Beijing Tiantan Hospital20 enrolled1 locationNCT06765733